Literature DB >> 30771311

Neuroprotective effects of agmatine in antineoplastic drugs induced neurotoxicity: In vitro study.

Damla Binnetoglu1, Ahmet Hacimuftuoglu2, Feyza Aricioglu3.   

Abstract

AIMS: The effects of agmatine, an endogenous substance known to have a neuroprotective effect against neurotoxicity has been investigated.
MATERIAL AND METHODS: The primary neuron culture obtained from neonatal rats was exposed to toxicity with paclitaxel and cisplatin and the effect of agmatine on both acute (1 h) and chronic (24 h) exposure was demonstrated by biochemical and molecular analyses. It was demonstrated that the effect of agmatine before and after agmatine was induced by neurotoxicity before agmatine and the effect of agmatine on the formed and occuring toxicities. In addition to the results of cell viability assay, total oxidant capacity and total antioxidant capacity, we have found the opportunity to elaborate on our molecular mechanisms by elaborating our findings with apoptotic and inflammation markers such as caspase 3, kaspase 9 and TNF alpha. KEY
FINDINGS: The results of our study revealed the effect profile of a protective molecule against pathological neural deaths due to neurodegeneration not only in neurotoxicity due to anticancer drugs. SIGNIFICANCE: In this context, we tried to reverse neurotoxicity due to anticancer drugs by using agmatine the duration (1 and 24 h) and dosage (10-5 M and 10-6 M) determined.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Agmatine; Cell culture; Cisplatin; Paclitaxel

Mesh:

Substances:

Year:  2019        PMID: 30771311     DOI: 10.1016/j.lfs.2019.02.018

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  1 in total

1.  Involvement of Mfn2, Bcl2/Bax signaling and mitochondrial viability in the potential protective effect of Royal jelly against mitochondria-mediated ovarian apoptosis by cisplatin in rats.

Authors:  Khalid S Hashem; Asmaa Mohammed M Hussein Elkelawy; Saber Abd-Allah; Nermeen A Helmy
Journal:  Iran J Basic Med Sci       Date:  2020-04       Impact factor: 2.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.